Iron deficiency in pediatric patients in long-term risperidone treatment

Journal of Child and Adolescent Psychopharmacology

Volumn 23, Issue 2, 2013, Pages 101-109

  Calarge, Chadi Albert ^a   Ziegler, Ekhard E ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; INTERLEUKIN 6; IRON; PROLACTIN; PSYCHOSTIMULANT AGENT; RISPERIDONE; TRANSFERRIN RECEPTOR;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CHILDHOOD DISEASE; CROSS-SECTIONAL STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; EXTERNALIZING DISORDER; FEMALE; FERRITIN BLOOD LEVEL; HOSPITALIZED ADOLESCENT; HOSPITALIZED CHILD; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON DEPLETION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PREVALENCE; PROLACTIN BLOOD LEVEL; PSYCHOPHARMACOTHERAPY; SCHOOL CHILD; SIDE EFFECT; TREATMENT RESPONSE; WEIGHT GAIN;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERLEUKIN-6; IRON; LINEAR MODELS; MALE; MENTAL DISORDERS; MULTIVARIATE ANALYSIS; PREVALENCE; PROLACTIN; RISPERIDONE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; WEIGHT GAIN;

EID: 84875460996     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2012.0046     Document Type: Article

References (50)

1. Achenbach TM, Rescorla LA: Manual for the ASEBA School-Age Forms & Profiles. Burlington, VT: Research Center for Children, Youth & Families, 2001.
2. Aman MG, McDougle CJ, Scahill L, Handen B, Arnold LE, Johnson C, Stigler KA, Bearss K, Butter E, Swiezy NB, Sukhodolsky DD, Ramadan Y, Pozdol SL, Nikolov R, Lecavalier L, Kohn AE, Koenig K, Hollway JA, Korzekwa P, Gavaletz A, Mulick JA, Hall KL, Dziura J, Ritz L, Trollinger S, Yu S, Vitiello B, Wagner A: Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. J AmAcad Child Adolesc Psychiatry 48:1143-1154, 2009.
3. Arnold LE, Farmer C, Kraemer HC, Davies M, Witwer A, Chuang S, DiSilvestro R, McDougle CJ, McCracken J, Vitiello B, Aman MG, Scahill L, Posey DJ, Swiezy NB: Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. J Child Adolesc Psychopharmacol 20:83-93, 2010.
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Text Revision. Fourth ed. Washington, DC: American Psychiatric Association, 2000.
5. Barkey RJ, Amit T, Ben-Shachar D, Youdim MB: Characterization of the hepatic prolactin receptors induced by chronic iron deficiency and neuroleptics. Eur J Pharmacol 122:259-267, 1986.
6. Beard JL, Chen Q, Connor J, Jones BC: Altered monamine metabolism in caudate-putamen of iron-deficient rats. Pharmacol Biochem Behav 48:621-624, 1994.
7. Beard JL, Connor JR: Iron status and neural functioning. Annu Rev Nutr 23:41-58, 2003.
8. Benito P, House W, Miller D: Comparison of oral and intraperitoneal iron supplementation in anaemic rats: A re-evaluation of the mucosal block theory of iron absorption. Br J Nutr 79:533-540, 1998.
9. Block G, Murphy M, Roullet JB, Wakimoto P, Crawford PB, Block T: Pilot validation of a FFQ for children 8-10 years (Abstract). Fourth International Conference On Dietary Assessment Methods, Tucson, Arizona, 2000.
10. Burhans MS, Dailey C, Beard Z, Wiesinger J, Murray-Kolb L, Jones BC, Beard JL: Iron deficiency: Differential effects on monoamine transporters. Nutr Neurosci 8:31-38, 2005.
11. Calarge C, Farmer C, DiSilvestro R, Arnold LE: Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 20:495-502, 2010.
12. Calarge CA, Acion L, Kuperman S, Tansey M, Schlechte JA: Weight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents. J Child Adolesc Psychopharmacol 19:101-109, 2009a.
13. Calarge CA, Ellingrod VL, Acion L, Miller del D, Moline J, Tansey MJ, Schlechte JA: Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents. Pharmacogenet Genomics 19:373-382, 2009b.
14. Calarge CA, Miller DD: Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents. J Child Adolesc Psychopharmacol 21:163-169, 2011.
15. Calarge CA, Zimmerman B, Xie D, Kuperman S, Schlechte JA: A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys. J Clin Psychiatry 71:338-347, 2010.
16. Cepeda-Lopez AC, Aeberli I, Zimmermann MB: Does obesity increase risk for iron deficiency? A review of the literature and the potential mechanisms. Int J Vitam Nutr Res 80:263-270, 2010.
17. Comer JS, Olfson M, Mojtabai R. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007. J Am Acad Child Adolesc Psychiatry 49:1001-1010, 2010.
18. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 101:3359-3364, 2003.
19. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK: Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 302:1765-1773, 2009.
20. Cortese S, Lecendreux M, Bernardina BD, Mouren MC, Sbarbati A, Konofal E: Attention-deficit/hyperactivity disorder, Tourette's syndrome, and restless legs syndrome: The iron hypothesis. Med Hypotheses 70:1128-1132, 2008.
21. D'Amato TJ. Is iron deficiency causative of attention-deficit/ hyperactivity disorder? Arch Pediatr Adolesc Med 159:788, 2005.
22. Del Castillo N, Arnold LE, Aman M, Scahill L, McDougle C, McCraken JT, Calarge CA: Iron status and weight gain during antipsychotic treatment in children with pervasive developmental disorders. 59th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, California, 2012.
23. del Giudice EM, Santoro N, Amato A, Brienza C, Calabro P, Wiegerinck ET, Cirillo G, Tartaglione N, Grandone A, Swinkels DW, Perrone L: Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J Clin Endocrinol Metab 94:5102-5107, 2009.
24. Emiliano AB, Fudge JL: From galactorrhea to osteopenia: Rethinking serotonin-prolactin interactions. Neuropsychopharmacology 29:833-846, 2004.
25. Erikson KM, Jones BC, Beard JL: Iron deficiency alters dopamine transporter functioning in rat striatum. J Nutr 130:2831-2837, 2000.
26. Erikson KM, Jones BC, Hess EJ, Zhang Q, Beard JL: Iron deficiency decreases dopamine D1 and D2 receptors in rat brain. Pharmacol Biochem Behav 69:409-418, 2001.
27. Felt B, Jimenez E, Smith J, Calatroni A, Kaciroti N, Wheatcroft G, Lozoff B: Iron deficiency in infancy predicts altered serum prolactin response 10 years later. Pediatr Res 60:513-517, 2006.
28. Fuglestad AJ, Lehmann AE, Kroupina MG, Petryk A, Miller BS, Iverson SL, Johnson DE, Georgieff MK: Iron deficiency in international adoptees from Eastern Europe. J Pediatr 153:272-277, 2008.
29. Fuqua BK, Vulpe CD, Anderson GJ: Intestinal iron absorption. J Trace Elem Med Biol 26:115-119, 2012.
30. Georgieff MK, Landon MB, Mills MM, Hedlund BE, Faassen AE, Schmidt RL, Ophoven JJ, Widness JA: Abnormal iron distribution in infants of diabetic mothers: Spectrum and maternal antecedents. J Pediatr 117:455-461, 1990.
31. Georgieff MK, Wewerka SW, Nelson CA, Deregnier RA: Iron status at 9 months of infants with low iron stores at birth. J Pediatr 141:405-409, 2002.
32. Grantham-McGregor S, Ani C: A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr 131:649S-666S; discussion 666S-668S, 2001.
33. Guiang SF, 3rd, Georgieff MK, Lambert DJ, Schmidt RL, Widness JA: Intravenous iron supplementation effect on tissue iron and hemoproteins in chronically phlebotomized lambs. Am J Physiol 273:R2124-2131, 1997.
34. Hurrell R, Egli I: Iron bioavailability and dietary reference values. Am J Clin Nutr 91:1461S-1467S, 2010.
35. Konofal E, Lecendreux M, Arnulf I, Mouren MC: Iron deficiency in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 158:1113-1115, 2004.
36. Konofal E, Lecendreux M, Deron J, Marchand M, Cortese S, Zaim M, Mouren MC, Arnulf I: Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol 38:20-26, 2008.
37. Looker AC, Cogswell ME, Gunter EW: Iron Deficiency-United States, 1999-2000. In: MMWR Series. Atlanta, GA, CDC; 2002. Pp. 897-899.
38. Lozoff B, Georgieff MK: Iron deficiency and brain development. Semin Pediatr Neurol 13:158-165, 2006.
39. Lozoff B, Jimenez E, Hagen J, Mollen E, Wolf AW: Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics 105:E51, 2000.
40. Mohamed WM, Unger EL, Kambhampati SK, Jones BC: Methylphenidate improves cognitive deficits produced by infantile iron deficiency in rats. Behav Brain Res 216:146-152, 2011.
41. Nelson C, Erikson K, Pinero DJ, Beard JL: In vivo dopamine metabolism is altered in iron-deficient anemic rats. J Nutr 127:2282-2288, 1997.
42. Nemeth E, Ganz T: The role of hepcidin in iron metabolism. Acta Haematol 122:78-86, 2009.
43. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL: Centers for Disease Control and Prevention 2000 growth charts for the United States: Improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45-60, 2002.
44. Oner O, Alkar OY, Oner P: Relation of ferritin levels with symptom ratings and cognitive performance in children with attention deficithyperactivity disorder. Pediatr Int 50:40-44, 2008.
45. Sachdev P: The neuropsychiatry of brain iron. J Neuropsychiatry Clin Neurosci 5:18-29, 1993.
46. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME: NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): Description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 39:28-38, 2000.
47. Trumbo P, Schlicker S, Yates AA, Poos M: Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc 102:1621-1630, 2002.
48. Turner CA, Xie D, Zimmerman BM, Calarge CA: Iron status in toddlerhood predicts sensitivity to psychostimulants in children. J Atten Disord 16:295-303, 2012.
49. World Health Organization: Serum ferritin concentrations for the assessment of iron status and iron deficiency in populations. Geneva: World Health Organization; 2011.
50. Yang Z, Lonnerdal B, Adu-Afarwuah S, Brown KH, Chaparro CM, Cohen RJ, Domellof M, Hernell O, Lartey A, Dewey KG: Prevalence and predictors of iron deficiency in fully breastfed infants at 6 mo of age: Comparison of data from 6 studies. Am J Clin Nutr 89:1433-1440, 2009.